VMAT2 (Vesicular Monoamine Transporter 2) Activators belong to a distinct chemical category known for their interaction with the VMAT2 protein, a pivotal player in the neural communication system. VMAT2 is primarily located within the synaptic vesicles of neurons, where it assumes responsibility for the encapsulation and movement of monoamine neurotransmitters like dopamine, serotonin, and norepinephrine. These vesicles act as reservoirs, storing and subsequently releasing neurotransmitters, enabling the vital transmission of information between neurons. VMAT2 activators, as their name implies, influence the operation of this transporter, thereby impacting the release and accessibility of monoamines within the synaptic cleft.
The mechanism by which VMAT2 activation occurs is multifaceted and contingent on the specific compound in question. Generally, VMAT2 activators amplify the intake of monoamines into synaptic vesicles, elevating the reservoir of neurotransmitters available for release during neuronal signaling. This modulation can exert significant effects on neurotransmission, consequently influencing a myriad of physiological processes encompassing mood regulation, reward mechanisms, and motor control. Scientists are diligently investigating these compounds to unravel the intricate neurobiological mechanisms at play and gain insights into their implications for a range of conditions. VMAT2 activators thus constitute a fascinating class of substances that target a pivotal component of the neural communication system, offering valuable insights into the enigmatic world of neurotransmission in the human brain.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may enhance VMAT2 expression by activating adenylyl cyclase, thereby increasing cAMP levels and protein kinase A (PKA) activity, which can lead to transcriptional changes. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may upregulate VMAT2 expression through retinoic acid receptors (RARs), influencing gene transcription related to neurotransmitter system development and function. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
This form of vitamin D can induce VMAT2 expression by engaging vitamin D receptors (VDRs), affecting gene transcription in neural cells. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, may promote VMAT2 expression by altering chromatin structure, thus affecting gene accessibility for transcription. | ||||||
Pregnenolone sulfate sodium salt | 1852-38-6 | sc-301609 | 50 mg | $99.00 | 2 | |
Pregnenolone sulfate sodium salt might stimulate VMAT2 expression through modulatory effects on neurosteroid receptors, influencing neurotransmission. | ||||||
Tianeptine | 66981-73-5 | sc-213044 sc-213044A | 10 mg 50 mg | $250.00 $422.00 | ||
Tianeptine's influence on VMAT2 expression may be due to its effects on stress-related neuroplasticity and neurotransmitter modulation. | ||||||